322 related articles for article (PubMed ID: 21689002)
1. Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of western Iran.
Rahimi Z; Nourozi-Rad R; Vaisi-Raygani A; Saidi MR; Rahimi Z; Ahmadi R; Yarani R; Hamzehee K; Parsian A
Genet Test Mol Biomarkers; 2011 Nov; 15(11):813-9. PubMed ID: 21689002
[TBL] [Abstract][Full Text] [Related]
2. Strong interaction between T allele of endothelial nitric oxide synthase with B1 allele of cholesteryl ester transfer protein TaqIB highly elevates the risk of coronary artery disease and type 2 diabetes mellitus.
Rahimi Z; Nourozi-Rad R; Rahimi Z; Parsian A
Hum Genomics; 2012 Sep; 6(1):20. PubMed ID: 23157875
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
Hsieh MC; Tien KJ; Chang SJ; Lo CS; Hsin SC; Hsiao JY; Hsu SC; Liang HT; Chen HC; Shin SJ; Lin SR
Metabolism; 2007 Jun; 56(6):745-50. PubMed ID: 17512305
[TBL] [Abstract][Full Text] [Related]
4. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
[TBL] [Abstract][Full Text] [Related]
5. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
[TBL] [Abstract][Full Text] [Related]
6. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
Kaman D; İlhan N; İlhan N; Akbulut M
Bosn J Basic Med Sci; 2015 Feb; 15(1):9-13. PubMed ID: 25725138
[TBL] [Abstract][Full Text] [Related]
7. Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.
Li YY; Wu XY; Xu J; Qian Y; Zhou CW; Wang B
Mol Biol Rep; 2013 Feb; 40(2):1997-2014. PubMed ID: 23129316
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
Schierer A; Been LF; Ralhan S; Wander GS; Aston CE; Sanghera DK
Pharmacogenet Genomics; 2012 Feb; 22(2):95-104. PubMed ID: 22143414
[TBL] [Abstract][Full Text] [Related]
9. [Association between insulin resistance and cholesteryl ester transfer protein gene polymorphism in type 2 diabetes mellitus].
Jiang T; Song XX; Zhang M; Qi WH; Zhang XW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):298-301. PubMed ID: 15952120
[TBL] [Abstract][Full Text] [Related]
10. Association of APOE and CETP TaqIB Polymorphisms with Type 2 Diabetes Mellitus.
Srirojnopkun C; Kietrungwilaikul K; Boonsong K; Thongpoonkaew J; Jeenduang N
Arch Med Res; 2018 Oct; 49(7):479-485. PubMed ID: 30853126
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
[TBL] [Abstract][Full Text] [Related]
12. Association of cholesteryl ester transfer protein (CETP) gene polymorphism, high density lipoprotein cholesterol and risk of coronary artery disease: a meta-analysis using a Mendelian randomization approach.
Wu Z; Lou Y; Qiu X; Liu Y; Lu L; Chen Q; Jin W
BMC Med Genet; 2014 Oct; 15():118. PubMed ID: 25366166
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.
Arca M; Montali A; Ombres D; Battiloro E; Campagna F; Ricci G; Verna R
Clin Genet; 2001 Nov; 60(5):374-80. PubMed ID: 11903340
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between the cholesteryl ester transfer protein gene--TaqIB polymorphism and coronary restenosis following percutaneous transluminal coronary angioplasty and stenting: a pilot study.
Kaestner S; Patsouras N; Spathas DH; Flordellis CS; Manolis AS
Angiology; 2010 May; 61(4):338-43. PubMed ID: 19815603
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
Abd El-Aziz TA; Mohamed RH; Hagrass HA
J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
[TBL] [Abstract][Full Text] [Related]
17. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
Horne BD; Camp NJ; Anderson JL; Mower CP; Clarke JL; Kolek MJ; Carlquist JF;
J Am Coll Cardiol; 2007 May; 49(20):2053-60. PubMed ID: 17512363
[TBL] [Abstract][Full Text] [Related]
18. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
[TBL] [Abstract][Full Text] [Related]
19. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
[TBL] [Abstract][Full Text] [Related]
20. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
